
Genetic Testing for Clinics and Hospitals
Expand your diagnostic capabilities with specialty-specific exome sequencing, interpretation by geneticists, and comprehensive clinical reports.
A diagnostic laboratory serving your patients
All of our studies are based on whole-exome sequencing, which allows us to expand the analysis without repeating the sequencing process.
Whole-exome sequencing of more than 20,000 genes, which forms the basis of all our diagnostic studies.
Exome sequencing of the patient and both parents to identify de novo and inherited variants.
Analysis of more than 6,000 genes with proven clinical relevance, based on the entire exome.
Exome sequencing tailored to each patient's medical specialty and clinical presentation.
DG Preventive Studies on Predisposition to Hereditary Cancer and Cardiovascular Disease.
Comprehensive, with variants classified according to ACMG guidelines and specific clinical recommendations.
Genetic counselling
Our geneticists help you choose the most appropriate test for each patient and interpret the results.
Targeted exomes
Select a specialty to view its studies, the genes included, and the technical specifications.
An earlier diagnosis changes the patient's treatment plan
Exome and genome sequencing identify the genetic cause in more than one-third of children with suspected genetic disorders and, in many cases, lead to changes in their treatment or follow-up care.
Source: EURORDIS, Rare Barometer 2024, more than 10,000 patients from 42 countries
Performance of Genetic Testing in Children with Suspected Genetic Disorders
Source: Clark et al., npj Genomic Medicine 2018, meta-analysis of 37 studies and 20,068 children
Quality and Clinical Support
Each study follows a validated workflow involving laboratory procedures, bioinformatics, and data interpretation, which is reviewed by external evaluators each year.
- Health Registration
- Diagnostic Center C.2.5.6/6466, Principality of Asturias
- Certifications
- ISO 9001:2015 and ISO/IEC 27001:2022, certified by AENOR
- External Evaluation
- EMQN and GenQA Annual EQA Programs
- Validation
- Sanger sequencing for low-coverage variants and MLPA for CNVs on request
- Re-evaluation of VUS
- At 12 months: submit a new report if the classification changes, or notify the doctor if it does not change
- Clinical Support
- Medical Consultants in Neurology, Neuropediatrics, and Otolaryngology
How to Request a Study
- 1
Inquiry
Our geneticists will help you choose the most appropriate test for each patient.
- 2
Application
Online via Genome Lab at
Download sheet
or using the application form, along with the informed consent form. - 3
Sample
Sample shipping at no additional cost from your facility.
- 4
Report
Results report interpreted
by our geneticists.
Shall we talk about your patient?
We'll answer your questions about the most appropriate genetic test or send you a no-obligation quote.
- Response within 24 business hours
- Advice from our geneticists on choosing a test
- Sample shipping at no additional cost from your facility
